Navitoclax - CAS# 923564-51-6 Catalog No.:M10894-2 prostatitis

prostatitis

Capromorelin showed enhanced intestinal absorption in rodent models and exhibited superior pharmacokinetic properties

Navitoclax - CAS# 923564-51-6 Catalog No.:M10894-2 prostatitisNavitoclax, also known as ABT 263, is an orally bioavailable, synthetic small molecule antagonist of a subset of the B cell leukemia 2 (Bcl 2) family of proteins with potential antineoplastic activity. ABT 263 selectively binds to apoptosis suppressor proteins Bcl 2, Bcl XL, and Bcl w and prevents their binding to the apoptotic effectors Bax and Bak proteins, which may trigger apoptosis in tumor cells overexpressing Bcl 2, Bcl XL, and Bcl w. Product